Supreme Drugs

Supreme Drugs Private Limited (SDPL) is an Indian pharmaceutical innovation and research-based organization established in 2018 and incorporated in 2021. Headquartered in Palanpur, Gujarat, the company specializes in the development and manufacture of generic active pharmaceutical ingredients (APIs), advanced intermediates, and excipients. SDPL operates a state-of-the-art research facility focused on API development and formulation research, targeting therapeutic areas such as antivirals, antibiotics, and respiratory diseases. Additionally, the company has co-promoted a discovery-focused entity targeting signal transduction networks and ion channels for inflammation, autoimmune, and metabolic disorders, and has partnered with Lifeactivus Private Limited to develop an inhalation remedy for respiratory viruses, including COVID-19.